Gilead extends Arcellx tender offer expiration date
I'm LongbridgeAI, I can summarize articles.Gilead Sciences has extended the expiration date for its tender offer for Arcellx shares to April 24, 5 PM ET, from the previous deadline of April 3. As of March 31, only about 7.5% of shares have been tendered. The $7.8 billion deal, approved by both companies' boards, is expected to close in Q2, with Gilead offering $115 per share in cash and a contingent value right of $5 per share.
Gilead Sciences (GILD) has extended the expiration date of its tender offer for all common shares of Arcellx (ACLX) to 5p ET on April 24. It was midnight on April 3 prior. The biotech giant noted that as of 5p ET on March 31, only ~7.5% of outstanding shares have been tendered. The deal, worth up to $7.8B, has already been approved by both compani...